Terutroban sodium

Drug Profile

Terutroban sodium

Alternative Names: S-18886

Latest Information Update: 04 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boston University Medical Campus; Servier
  • Developer Servier
  • Class Anti-ischaemics; Antiplatelets; Antithrombotics; Naphthalenes; Propionic acids; Small molecules
  • Mechanism of Action Thromboxane A2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Atherosclerosis; Cerebral ischaemia; Coronary disorders; Peripheral vascular disorders; Thromboembolism

Most Recent Events

  • 03 Aug 2010 Servier terminates the phase III PERFORM trial in prevention of Thromboembolism (secondary prevention of ischaemic stroke)
  • 27 Jul 2007 Data presented at the 21st Congress of the International Society on Thrombosis and Haemostasis (ISTH-2007) added to the Thromboses pharmacodynamics section
  • 12 Jul 2007 Preclinical trials in Arterial thrombosis in France (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top